Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5% Minoxidil Foam in Female Androgenetic Alopecia
NCT07080931Phase 3Recruiting
- Sponsor
- Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.
- Start
- Feb 2025
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of minoxidil in androgenetic alopecia (AGA), sponsored by Zhejiang Sunshine Mandi Pharmaceutical Co., Ltd.. Started Feb 2025; status: recruiting.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT07080931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07080931.